News | July 23, 2009

Elekta Puts Comprehensive VMAT Solution on Center Stage at AAPM

VMAT

July 23, 2009 - Elekta will demonstrate how the its comprehensive VMAT solution can help healthcare providers deliver cancer care with precision and ease at the 2009 American Association of Physicists in Medicine (AAPM) annual meeting, July 26-30 in Anaheim, Calif.
Offering a sophisticated set of tools to plan and deliver radiation treatments, Elekta booth 423 will highlight treatment planning software, an oncology-specific EMR, and a fully integrated treatment system designed to offer precision, speed and control.
An advanced, clinically relevant IMRT planning system, Monaco brings helps make the planning process easier, more straightforward and clinically reliable. New VMAT tools enable users to create arc-based treatment plans using all of the features already available in Monaco. With reduced planning time and increased clinical throughput, Monaco with VMAT optimizes single or multiple non-coplanar arcs simultaneously, providing the flexibility and control needed for complex treatment plans.
Elekta’s oncology EMR, MOSAIQ 2.0, is said to increase productivity, elevate efficiency and facilitate high-quality patient care. Complete with new connectivity, new functions and database enhancements, while preserving the user interface MOSAIQ supports the entire cancer team by uniting diverse systems and devices.
Elekta Infinity integrates the most advanced capabilities available with reported ease of use. The only fully integrated treatment system that allows personalization of imaging and treatment workflows, according to the manufacturer, Infinity can reduce IMRT treatment sessions with the flexibility of multiple arcs to improve conformance.
Elekta also plans to host several education seminars and events in conjunction with the annual meeting.
For more information: elekta.com/aapmevents

Related Content

A new hybrid X-ray detector developed by the University of Surrey outperforms commercial devices — and could lead to more accurate cancer therapy.
News | X-Ray | December 03, 2020
December 3, 2020 — A new hybrid X-ray detector deve
For men with early-stage prostate cancer, choices about initial treatment carry varying risks of "financial toxicity," reports a study in The Journal of Urology, Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.

Getty Images

News | Prostate Cancer | December 02, 2020
December 2, 2020 — ...
During active surveillance, prostate cancer is carefully monitored for signs of progression through regular prostate-specific antigen (PSA) screening, prostate exams, imaging, and repeat biopsies.

Getty Images

News | Prostate Cancer | November 18, 2020
November 18, 2020 — ...
Minimizing delays to treatment could improve cancer survival rates, say researchers

Getty Images

News | Radiation Oncology | November 10, 2020
November 10, 2020 — People whose treatment for cancer is delayed by even one month have in many cases a 6 to 13% high
Watch-and-Wait Compared to Operation for Patients with Complete Response to Neoadjuvant Therapy for Rectal Cancer. Image courtesy of the American College of Surgeons

Watch-and-Wait Compared to Operation for Patients with Complete Response to Neoadjuvant Therapy for Rectal Cancer. Image courtesy of the American College of Surgeons

News | Radiation Therapy | November 02, 2020
November 2, 2020 — A nonsurgical treatment option for...
Conceptual diagram of bio-organizational crushing technology based on high-intensity concentric ultrasonography. Image courtesy of Korea Institue of Science and Technology(KIST)

Conceptual diagram of bio-organizational crushing technology based on high-intensity concentric ultrasonography. Image courtesy of Korea Institue of Science and Technology(KIST)

News | Ultrasound Imaging | November 02, 2020
November 2, 2020 — Focusing ultrasound energy on a target site in the body to generate heat can burn and destroy the
Updated results of NRG Oncology trial display effectiveness of gemcitabine and daily radiation for bladder preservation in muscle-invasive bladder cancer patients
News | Radiation Oncology | November 02, 2020
November 2, 2020 — Bladder preservation with trimodality therapy can be a safe and effective alternative to cystectom
Follow up results on first multicenter trial to report outcomes of salvage low dose radiotherapy brachytherapy after external beam radiotherapy for prostate cancer
News | Prostate Cancer | October 30, 2020
October 30, 2020 — Researchers involved in the...